Physician profile
William Yao
NPI 1831429893
$153,683.73
in general payments reported to CMS, 2019-2025
18 companies · $18K in 2025
The $18K reported for 2025 was more than what 98% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $26K · 2020: $8,712 · 2021: $12K · 2022: $18K · 2023: $37K · 2024: $34K · 2025: $18K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $50K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $26K · Travel and Lodging: $6,924 · Food and Beverage: $5,897.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $49,562.99 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $26,404.50 |
| Travel and Lodging | $6,924.32 |
| Food and Beverage | $5,896.86 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Optinose US, INC. | $78,285.67 | 2019-2025 | |
| Acclarent, INC | $22,114.74 | 2019-2023 | Acclarent Balloon Inflation Device, Relieva Spinplus, Trudi Nav Cable |
| Aerin Medical INC. | $18,831.96 | 2019-2025 | |
| Genzyme Corporation | $18,218.76 | 2021-2025 | |
| Stryker Corporation | $5,891.29 | 2019-2025 | 1788, Clarifix Cryotherapy Device, Core |
| Medtronic, INC. | $5,043.92 | 2022-2025 | Stealthstation S8 Platform, Propel, V-Loc 180 |
| Integra Lifesciences Corporation | $2,300.85 | 2024-2025 | Acclarent Aera, Integra, Inspira Air |
| Intersect Ent, INC. | $1,577.51 | 2019-2022 | |
| Neurent Medical Limited | $427.05 | 2022-2024 | Neuromark Device, Neuromark Radiofrequency Console |
| 3-D Matrix, INC. | $398.74 | 2025 | |
| Tactile Systems Technology INC | $141.94 | 2024 | Entre Plus, Flexitouch Plus |
| Zimmer Biomet Holdings, INC. | $135.18 | 2022 | |
| Spirair, INC. | $119.05 | 2024 | Septalign |
| Regeneron Healthcare Solutions, INC. | $107.13 | 2025 | Dupixent |
| Paratek Pharmaceuticals, INC. | $34.02 | 2025 | Xhance |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $24.37 | 2025 | Tezspire |
| Astrazeneca Pharmaceuticals LP | $17.92 | 2025 | Tezspire |
| Merck Sharp & Dohme LLC | $13.63 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Yao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.